Skip to main content
Log in

Unveiling the link between lifestyle risk factors and diabetic retinopathy

  • Review Article
  • Published:
International Journal of Diabetes in Developing Countries Aims and scope Submit manuscript

Abstract

Introduction

Diabetic retinopathy (DR) is recognized as a significant complication of diabetes and continues to be a prominent contributor to global blindness. Epidemiological investigations have pinpointed various lifestyle risk factors accountable for the onset and progression of DR. However, pinpointing the most influential factors is challenging due to variability in ethnic background, study design, and sample size in previous research.

Methodology

In the present study, a systematic and comprehensive review was conducted to identify significant factors contributing to DR development. Following the PRISMA guidelines, 322 articles were screened, and six articles discussing various lifestyle factors were included.

Result

Elevated blood sugar levels (hyperglycemia), abnormal lipid profiles (dyslipidemia), high blood pressure (hypertension), and the duration of diabetes have been identified as the predominant lifestyle risk factors associated with the development and progression of DR. Furthermore, male gender was also linked to the occurrence of DR.

Conclusion

While gender is beyond control, the other identified factors associated with DR can be managed through improved eating habits and regular exercise. Future investigations should prioritize exploring the collective influence of these factors on the development and progression of DR.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

Data availability

No data was used for the research described in the article.

References

  1. Kumar A, Gangwar R, Ahmad Zargar A, Kumar R, Sharma A. Prevalence of diabetes in India: a review of IDF Diabetes Atlas 10th edition. Curr Diabetes Rev. 2023.

  2. International Diabetes Federation. Diabetes facts and figures. Available online: https://idf.org/aboutdiabetes/what-is-diabetes/facts-figures.html. Accessed 9 Dec 2021.

  3. Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, Magliano DJ. IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119.

    Article  PubMed  Google Scholar 

  4. Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, IDF Diabetes Atlas Committee. Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas. Diabetes Res Clin Pract, 2019;157, 107843.

  5. Mrugacz M, Bryl A, Zorena K. Retinal vascular endothelial cell dysfunction and neuroretinal degeneration in diabetic patients. J Clin Med. 2021;10:458.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  6. Ting DSW, Cheung GCM, Wong TY. Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review. Clin Exp Ophthalmol. 2016;44:260–77.

    Article  PubMed  Google Scholar 

  7. Yau JWY, Rogers SL, Kawasaki R, Lamoureux EL, Kowalski JW, Bek T, et al. Global prevalence and major risk factors of diabetic retinopathy. Diabetes Care. 2012;35:556–64.

    Article  PubMed  PubMed Central  Google Scholar 

  8. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. Bri Med J. 1998;317:703–13.

    Article  Google Scholar 

  9. Brownlee M. Biochemistry and molecular cell biology of diabetic complications. Nature. 2001;414(6865):813–20.

    Article  CAS  PubMed  Google Scholar 

  10. Brownlee M. The pathobiology of diabetic complications: a unifying mechanism. Diabetes. 2005;54(6):1615–25.

    Article  CAS  PubMed  Google Scholar 

  11. Kowluru RA, Abbas SN. Diabetes-induced mitochondrial dysfunction in the retina. Invest Ophthalmol Vis Sci. 2003;44(12):5327–34.

    Article  PubMed  Google Scholar 

  12. Li W, Liu X, Yanoff M, Cohen S, Ye X. Cultured retinal capillary pericytes die by apoptosis after an abrupt fluctuation from high to low glucose levels: a comparative study with retinal capillary endothelial cells. Diabetologia. 1996;39:537–47.

    Article  CAS  PubMed  Google Scholar 

  13. Perrott RL, North RV, Drasdo N, Ahmed KA, Owens DR. The influence of plasma glucose upon pulsatile ocular blood flow in subjects with type II diabetes mellitus. Diabetologia. 2001;44:700–5.

    Article  CAS  PubMed  Google Scholar 

  14. Fort PE, Losiewicz MK, Reiter CE, Singh RS, Nakamura M, Abcouwer SF, Barber AJ, Gardner TW. Differential roles of hyperglycemia and hypoinsulinemia in diabetes induced retinal cell death: evidence for retinal insulin resistance. PloS one. 2011;6(10):e26498.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  15. Ahmed KR, Karim MN, Bhowmik B, Habib SH, Bukht MS, Ali L, Hussain A. Incidence of diabetic retinopathy in Bangladesh: a 15-year follow-up study. J Diabetes. 2012;4(4):386–91.

    Article  PubMed  Google Scholar 

  16. Foo V, Quah J, Cheung G, Tan NC, Ma Zar KL, Chan CM, Lamoureux E, Tien Yin W, Tan G, Sabanayagam C. HbA1c, systolic blood pressure variability and diabetic retinopathy in Asian type 2 diabetics. J Diabetes. 2017;9(2):200–7.

    Article  CAS  PubMed  Google Scholar 

  17. Moh A, Neelam K, Zhang X, Sum CF, Tavintharan S, Ang K, Lee SBM, Tang WE, Lim SC. Excess visceral adiposity is associated with diabetic retinopathy in a multiethnic Asian cohort with longstanding type 2 diabetes. Endocr Res. 2018;43(3):186–94.

    Article  PubMed  Google Scholar 

  18. Yuan J, Zhang L, Jia P, Xin Z, Yang JK. Early onset age increased the risk of diabetic retinopathy in type 2 diabetes patients with duration of 10–20 years and HbA1C ≥7%: a hospital-based case-control study. Int J Endocrinol. 2021;10(2021):5539654.

    Google Scholar 

  19. Rani PK, Raman R, Chandrakantan A, Pal SS, Perumal GM, Sharma T. Risk factors for diabetic retinopathy in self-reported rural population with diabetes. J Postgrad Med. 2009;55(2):92.

    Article  CAS  PubMed  Google Scholar 

  20. Susarla G, Rizza AN, Li A, Han S, Khan R, Chan W, Sobrin L. Younger age and albuminuria are associated with proliferative diabetic retinopathy and diabetic macular edema in the South Indian GeNetics of DiAbeTic Retinopathy (SIGNATR) Study. Curr Eye Res. 2022;47(10):1416–23.

    Article  CAS  Google Scholar 

  21. Wild S, Roglic G, Green A, Sicree R, King H. Lobal prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047–53.

    Article  PubMed  Google Scholar 

  22. Bamashmus MA, Gunaid AA, Khandekar RB. Diabetic retinopathy, visual impairment and ocular status among patients with diabetes mellitus in Yemen: a hospital-based study. Indian J Ophthalmol. 2009;57(4):293–8.

    Article  PubMed  PubMed Central  Google Scholar 

  23. Liu L, Wu J, Yue S, Geng J, Lian J, Teng W, Huang D, Chen L. Incidence density and risk factors of diabetic retinopathy within type 2 diabetes: a five-year cohort study in China (report 1). Int J Environ Res Public Health. 2015;12(7):7899–909.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  24. Yoshida Y, Hagura R, Hara Y, Sugasawa G, Akanuma Y. Risk factors for the development of diabetic retinopathy in Japanese type 2 diabetic patients. Diabetes Res Clin Pract. 2001;51:195–203.

    Article  CAS  PubMed  Google Scholar 

  25. Klein R, Klein BE, Moss SE, Cruickshanks KJ. The wisconsin epidemiologic study of diabetic retinopathy: XIV. Ten-year incidence and progression of diabetic retinopathy. Arch Ophthalmol. 1994;112(9):1217–28.

    Article  CAS  PubMed  Google Scholar 

  26. Haffner SM, Fong D, Stern MP, Pugh JA, Hazuda HP, Patterson JK, Klein R. Diabetic retinopathy in Mexican Americans and non-Hispanic whites. Diabetes. 1988;37(7):878–84.

    Article  CAS  PubMed  Google Scholar 

  27. Nelson RG, Wolfe JA, Horton MB, Pettitt DJ, Bennett PH, Knowler WC. Proliferative retinopathy in NIDDM: incidence and risk factors in Pima Indians. Diabetes. 1989;38(4):435–40.

    Article  CAS  PubMed  Google Scholar 

  28. Namperumalsamy P, Kim R, Vignesh TP, Nithya N, Royes J, Gijo T, Vijayakumar V. Prevalence and risk factors for diabetic retinopathy: a population-based assessment from Theni District, south India. Postgrad Med J. 2009;85(1010):643–8.

    Article  CAS  PubMed  Google Scholar 

  29. Sikka R, Raina P, Soni R, Gupta H, Bhanwer AJS. Genomic profile of diabetic retinopathy in a north Indian cohort. Mol Biol Rep. 2023;50:1–10.

    Article  Google Scholar 

  30. Davis MD, Fisher MR, Gangnon RE, Barton F, Aiello LM, Chew EY, Ferris FL, Knatterud GL. Risk factors for high-risk proliferative diabetic retinopathy and severe visual loss: Early Treatment Diabetic Retinopathy Study Report# 18. Invest Ophthalmol Visual Sci. 1998;39:233–52.

    CAS  Google Scholar 

  31. Salinero-Fort MA, San Andres-Rebollo FJ, de Burgos-Lunar C, Arrieta-Blanco FJ, Gomez-Campelo P, MADIABETES Group. Four-year incidence of diabetic retinopathy in a Spanish cohort: the MADIABETES study. PLoS One, 2013;8(10), e76417

  32. WHO. Hypertension. 2023. https://www.who.int/news-room/fact-sheets/detail/hypertension.

  33. Snow V, Weiss KB, Mottur-Pilson C. Clinical Efficacy Assessment Subcommittee of the American College of Physicians*.  The evidence base for tight blood pressure control in the management of type 2 diabetes mellitus. Annals Internal Med, 2003;138(7), 587-592.

  34. United Kingdom Prospective Diabetes Study Group.UK Prospective Diabetes Study 30: diabetic retinopathy at diagnosis of type 2 diabetes and associated risk factors. Arch Ophthalmol 1998; 116:297–303.

  35. Landmesser ULF, Hornig B, Drexler H. Endothelial dysfunction in hypercholesterolemia: mechanisms, pathophysiological importance, and therapeutic interventions. In Semin Thromb Hemost. 2000;26:529–38.

    Article  CAS  Google Scholar 

  36. Huang Q, Yuan Y. Interaction of PKC and NOS in signal transduction of microvascular hyperpermeability. Am J Physiol-Heart Circ Physiol. 1997;273:H2442-51.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Himanshu Gupta or Ruhi Sikka.

Ethics declarations

Ethical approval

Not applicable.

Competing interests

The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary Information

Below is the link to the electronic supplementary material.

Supplementary file1 (XLSX 12 KB)

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Upadhayay, P., Singh, N., Pandey, M. et al. Unveiling the link between lifestyle risk factors and diabetic retinopathy. Int J Diabetes Dev Ctries (2024). https://doi.org/10.1007/s13410-024-01332-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s13410-024-01332-6

Keywords

Navigation